Penn Pharma appoints Wyeth’s Edward Rowland

pharmafile | January 20, 2011 | Appointment | Manufacturing and Production, Research and Development Edward Rowland, Penn Pharma, appointment, manufacturing and production, research and development 

Edward Rowland has joined Wales-based pharmaceutical drug developer and manufacturer Penn Pharma as head of operational analytical services.

He moves to the firm from Wyeth Research and has 15 years experience in the industry having previously held R&D, commercial and analytical development roles.

At Penn Pharma Edward will manage a team of 45 analytical chemists to provide clients with reputable analytical support across a wide variety of clinical and commercial product development programmes.

Advertisement

He said: “Penn’s analytical development has over 25 year’s experience in provision of practical, effective and compliant analytical solutions for its clients and I am looking forward to building on this reputation for excellence in my new role.”

Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

Rotzinger launches modular filling and capping platform for over-the-counter products

Rotzinger PharmaPack has launched a new filling and capping platform called VarioFill, designed to handle …

AAX Biotech announces collaboration for cardiovascular antibody therapy

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

The Gateway to Local Adoption Series

Latest content